ERCC1 and non-small cell lung carcinoma: For example, among patients with non-small-cell lung cancer treated with platinum derivatives, increased risk for high-grade gastrointestinal toxicity was not seen in carriers of the C allele of the ERCC1 gene (associated with lower ERCC1 transcript stability and lower protein levels), but in carriers of the A allele (51).